TY - JOUR T1 - Physiotherapy interventions on chest wall mobility in obstructive lung diseases: a systematic review JF - European Respiratory Journal JO - Eur Respir J DO - 10.1183/13993003.congress-2021.PA325 VL - 58 IS - suppl 65 SP - PA325 AU - Funda Akuzum AU - Aybike Senel AU - Basak Polat AU - Kubra Koce AU - Goksen Kuran Aslan Y1 - 2021/09/05 UR - http://erj.ersjournals.com/content/58/suppl_65/PA325.abstract N2 - Background: Physiotherapy interventions have a positive effect on increasing chest wall mobility in obstructive lung diseases.Aims and objectives: The purpose of this systematic review was to summarize evidence of physiotherapy interventions increasing chest mobility in obstructive lung diseases.Methods: Searches were performed in PEDro, Pubmed and Cochrane Central Register of Controlled Trials databases without language restrictions between 2010 and 25th December 2020. Randomized controlled trials (RCTs) investigating physiotherapy interventions on chest wall mobility were included. Two independent reviewers screened studies, extracted data, and assessed methodological quality of included studies. The assessment of risk of bias was conducted using the PEDro scale for RCTs. The articles were excluded if they have less than 5 out of 10 score.Results: Five studies included had good to excellent quality. A total of 139 patients were included in all RCTs. Intervention duration ranged from a single session to 12 weeks and the intervention schedules varied, consisting of 1-24 sessions, lasting 5-45 minutes per sessions. Three studies used respiratory muscle stretching and releasing techniques, one study combined respiratory muscle stretching with aerobic training, and one study planned diaphragmatic breathing. Four studies assessed chest wall mobility with optoelectronic plethysmography, whereas one study used measuring tape.Conclusions: The result of this first systematic review that investigates the effects of physiotherapy interventions on chest wall mobility in obstructive lung diseases suggests that more and better quality RCTs with objective measurement tools are required.FootnotesCite this article as: European Respiratory Journal 2021; 58: Suppl. 65, PA325.This abstract was presented at the 2021 ERS International Congress, in session “Prediction of exacerbations in patients with COPD”.This is an ERS International Congress abstract. No full-text version is available. Further material to accompany this abstract may be available at www.ers-education.org (ERS member access only). ER -